Table 2. Outcome of imatinib discontinuation in 8 patients.

Patient (No)	Age	Initial dose	Months to CMR	Months of treatment duration	Months of imatinib interruption
2*	43	100 mg/d	4	4.5	48
3*	28	200 mg/d	3	12	2
4*	38	100 mg/d	3	24	12
5*	34	100 mg/d	4	18	5
6	73	100 mg/d	2	24	74
7	41	100 mg/d	2	8	39
8	32	100 mg/d	3	20	55
9	32	100 mg/d	3	18	2

^*Hematologic relapse